Orthofix Medical Inc. (OFIX)

Market Cap	643.87M
Revenue (ttm)	799.49M
Net Income (ttm)	-126.00M
Shares Out	39.02M
EPS (ttm)	-3.30
PE Ratio	n/a
Forward PE	137.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	154,814
Open	16.93
Previous Close	16.74
Day's Range	16.46 - 17.00
52-Week Range	12.08 - 20.73
Beta	1.06
Analysts	Strong Buy
Price Target	23.33 (+41.39%)
Earnings Date	May 6, 2025

About OFIX

Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, de...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 1,616
• Stock Exchange: NASDAQ
• Ticker Symbol: OFIX
• Website: https://orthofix.com

Financial Performance

In 2024, Orthofix Medical's revenue was $799.49 million, an increase of 7.08% compared to the previous year's $746.64 million. Losses were -$126.00 million, -16.78% less than in 2023.

Analyst Forecast

According to 4 analysts, the average rating for OFIX stock is "Strong Buy." The 12-month stock price forecast is $23.33, which is an increase of 41.39% from the latest price.

Price Target

$23.33

(41.39% upside)

Analyst Consensus: Strong Buy